Interference No. 103,625 contain a written description of specific tumor necrosis factor binding proteins which includes the end portion, Leu Arg Glu, of the recited sequence in the LeMaire patent claims. In addition, Wallach point out that the ‘072 application identifies X as “probably 4 Thr” where claims 1-3 of the LeMaire patent require Pro at this position. LeMaire claims 1-3 LeMaire claims 1-3 read as follows; 1. (as corrected by Certificate of Correction of November 29, 1994) A purified and isolated TNF"-binding protein which has a molecular weight of about 42,000 daltons and has at the N terminus the amino acid sequence Xaa Thr Pro Tyr Ala Pro Glu Pro Gly Ser Thr Cys Arg Leu Arg Glu where Xaa is hydrogen, a phenylalanine residue (Phe) or the amino acid sequences Ala Phe, Val Ala Phe, Gln Val Ala Phe, Ala Gln Val Ala Phe, Pro Ala Gln Val Ala Phe or Leu Pro Ala Gln Val Ala Phe. 2. A protein as claimed in claim 1 in deglycosylated form. 3. A process for the preparation of a protein which has a molecular weight of about 42,000 daltons and has at the N terminus the amino acid sequence Xaa Thr Pro Tyr Ala Pro Glu Pro Gly Ser Thr Cys Arg Leu Arg Glu where Xaa is hydrogen, a phenylalanine residue (Phe) or the amino acid sequences Ala Phe, Val Ala Phe, Gln Val Ala Phe, Ala Gln Val Ala Phe, Pro Ala Gln Val Ala Phe or Leu Pro Ala Gln Val Ala Phe, which comprises concentration of the urine of patients with fever and subsequent purification of the retentate obtained in this way by ion exchange and affinity chromatography. While claim 1 recites “[A] purified and isolated TNF"-binding protein, the claim, in fact, is directed to a genus of eight purified and isolated TNF"-binding proteins having a molecular weight of about 42,000 daltons containing specific N terminus amino acid sequences. The eight purified and isolated TNF"-binding proteins have the following N terminus amino acid sequences: 9Page: Previous 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 NextLast modified: November 3, 2007